| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Oct 24 | UNCY Unicycive Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 5,500,000 | 0.00 | 9,970,152 |
| 9 Oct 24 | UNCY Unicycive Therapeutics | Series A-2 Prime Preferred Stock Common Stock | Sale back to company | Dispose D | Yes | No | 1000 | 2,695 | 2.70 mm | 3,885.21 |
| 9 May 24 | GERN Geron | Stock Option Common Stock | Grant | Acquire A | No | No | 3.88 | 180,000 | 698.40 k | 180,000 |
| 29 Dec 23 | GERN Geron | Common Stock | Grant | Acquire A | No | No | 0 | 1,970 | 0.00 | 1,970 |
| 26 Nov 23 | GERN Geron | Stock Option Common Stock | Grant | Acquire A | No | No | 1.97 | 200,000 | 394.00 k | 200,000 |
